NTBL Notable Labs Inc.: Bozor kapitallashuvining balans qiymatiga nisbati

Notable Labs, Ltd. (NTBL) sun'iy intellektga asoslangan tirik hujayralarni skrining qilishni ekspress biosample yetkazib berish tizimi bilan birlashtirib, sog'liqni saqlash gigantlari bilan B2B sheriklikni yaratmoqda. GURU.Markets platformasidagi bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati ushbu sinergiyani vizuallashtiradi, bunda joriy parametr 0.33 ga tengdir. Biroq, muvaffaqiyat platformaning kliniklarda joriy etilishiga va cheklangan kapital rezervlari sharoitida tadqiqot va ishlanmalar (R&D) xarajatlarining qat'iy nazoratiga bog'liq.

Notable Labs, Ltd. (NTBL) - Bozor kapitallashuvining balans qiymatiga nisbati 21.02.2024dan 02.11.2024gacha

NTBL (Notable Labs Ltd): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Notable Labs, Ltd.|NTBL - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Notable Labs Inc.|NTBL - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Notable Labs|NTBL - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati notablelabs.com|NTBL - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Notable Labs, Ltd.|NTBL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Notable Labs Inc.|NTBL - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Notable Labs Inc.
Fundamental baholash:NTBL (Notable Labs, Ltd.)

Notable Labs, Ltd. (NTBL) ventura kapitalidan foydalangan holda onkologik terapiyalarni shaxsiylashtirish uchun AI platformasini ishlab chiqmoqda. Ushbu narxning buki ko'rsatkichi biznes qiymatining uning sof aktivlariga nisbatan premiumi yoki diskontini aks ettiradi. Ushbu metrika joriy bozor kapitalizatsiyasini kapitalga bo'lish orqali hisoblanadi. Ushbu ko'rsatkichning sanoat o'rtacha qiymatlaridan pastga tushishi "qiymat tuzog'i" xavfi haqida signal beradi. Startap uchun bu spekulyativ optimizmni resurslarining haqiqiy qiymati bilan muvozanatga keltirish vositasi bo'lib xizmat qiladi.

Asosiy raqobatchilar

BeiGene Ltd (ONC) - Bozor qiymatining balans qiymatiga nisbati|halozyme.com (HALO) - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Protara Therapeutics - Kapitallashuvning sof aktivlarga nisbati|FATE: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aadibio.com WHWK|TScan Therapeutics, Inc. (TCRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CSBR (Champions Oncology Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBIT|Bozor qiymatining balans qiymatiga nisbati CEL-SCI Corporation CVM|Kapitallashuvning balans qiymatiga nisbati OSTX (ostherapies.com)|RADX: Bozor qiymatining balans qiymatiga nisbati|ARTV - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Adlai Nortye Limited ANL|VERU - Bozor kapitallashuvining balans qiymatiga multiplikatori|TPST: Bozor kapitallashuvining balans qiymatiga nisbati|Xilio Therapeutics (XLO) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Renovaro Biosciences|Bozor qiymatining balans qiymatiga nisbati MURA|Bozor qiymatining balans qiymatiga nisbati Kairos Pharma Ltd (KAPA)|Bozor qiymatining balans qiymatiga nisbati onkuretherapeutics.com (OKUR)|GDTC: Bozor kapitallashuvining balans qiymatiga nisbati|CRIS - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Apollomics Corp (APLM)|THAR: Balans qiymatiga nisbatan bozor qiymati|advanbiomed.com (ADVB) - Bozor qiymatining balans qiymatiga nisbati|Genprex Inc (GNPX) - Bozor qiymatining balans qiymatiga nisbati|CLDI (Calidi Biotherapeutics Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati sunshinebiopharma.com|Bozor kapitallashuvining balans qiymatiga nisbati Xenetic Biosciences (XBIO)|Bozor qiymatining balans qiymatiga nisbati SLRX (Salarius Pharmaceuticals Inc)|Bozor qiymatining balans qiymatiga nisbati PPBT|AONC - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati BeiGene, Ltd. (BGNE)|CKPT: Balans qiymatiga nisbatan bozor qiymati|Elevation Oncology (ELEV) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati iCAD|Ikena Oncology Inc. (IKNA) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori Viracta|Bozor kapitallashuvining balans qiymatiga nisbati MorphoSys AG MOR|Kapitallashuvning balans qiymatiga nisbati nayabiosciences.com NAYA|Kapitallashuvning sof aktivlarga nisbati AAPGV